Percent Free Fraction Phenytoin Calculator
Calculate measured or estimated free phenytoin fraction (%) to support therapeutic drug monitoring decisions.
How to Calculate Percent Free Fraction Phenytoin Accurately
Phenytoin is one of the most clinically important antiepileptic drugs in therapeutic drug monitoring because its pharmacokinetics are nonlinear and its protein binding is high. In most adults, approximately 90% of circulating phenytoin is protein-bound, mainly to albumin, while only around 10% is free. The free fraction is the pharmacologically active portion that enters tissues, exerts antiseizure effects, and contributes to concentration-related toxicity. Because of this, clinicians increasingly evaluate percent free fraction phenytoin when albumin is low, renal function is impaired, critical illness is present, or total and clinical picture do not match.
The basic equation is straightforward:
If free phenytoin is directly measured in the laboratory, this equation gives the most reliable patient-specific estimate. When free concentration is not available, clinicians often estimate altered binding using albumin-based correction equations. These estimates are useful for screening but should not replace measured free levels in unstable or high-risk patients.
Why Total Level Alone Can Be Misleading
A patient can appear “therapeutic” by total concentration but still be functionally supratherapeutic if the free fraction is elevated. This occurs in hypoalbuminemia, severe uremia, burns, critical illness, and multi-drug interactions that displace binding. Conversely, a low total level can coexist with an adequate free concentration, which may lead to unnecessary dose increases if free fraction is not considered.
- Typical therapeutic total: 10 to 20 mcg/mL
- Typical therapeutic free: 1 to 2 mcg/mL
- Typical expected free fraction: around 8% to 12% in stable adults with normal albumin
Direct vs Estimated Free Fraction
For direct calculation, enter measured total and measured free concentrations from the same sampling window. For estimated calculation, this page uses albumin and renal status assumptions to approximate expected free fraction. In normal renal function, reduced albumin often increases free fraction moderately. In significant uremia or ESRD, displacement by retained solutes may increase free fraction further even when albumin is not profoundly low.
| Clinical Situation | Common Total Phenytoin Interpretation Risk | Typical Free Fraction Pattern | Clinical Action |
|---|---|---|---|
| Normal albumin, stable outpatient | Low risk of major binding mismatch | Usually about 8% to 12% | Total often acceptable for routine checks; free level optional |
| Albumin below 3.5 g/dL | Total may underestimate active drug | Often increases into low-to-mid teens or higher | Prefer measured free level if symptomatic or dose changes planned |
| Uremia or ESRD | Total can significantly underrepresent active exposure | Can rise substantially, sometimes near 15% to 25%+ | Measured free phenytoin strongly preferred |
| ICU, sepsis, major burns, multi-drug therapy | Unpredictable binding and distribution | Variable and dynamic | Trend free concentrations and correlate with neurologic exam |
Step-by-Step Practical Use of This Calculator
- Enter the total phenytoin concentration in mcg/mL.
- If available, enter measured free phenytoin from the same blood draw period.
- If no free level is available, enter albumin and choose renal status.
- Choose calculation mode:
- Auto: uses measured free if present, otherwise estimated method.
- Direct: forces direct measured formula.
- Estimate: uses albumin-based estimation.
- Click Calculate to view free fraction, bound fraction, estimated free concentration (if applicable), and interpretation guidance.
Interpretation Bands for Percent Free Fraction
The exact clinically acceptable fraction varies by patient context, but a useful working interpretation is:
- 8% to 12%: common in patients with typical albumin binding.
- 12% to 18%: increased free exposure possible; assess symptoms and free absolute concentration.
- Above 18%: high unbound proportion; toxicity risk rises if total is also elevated.
Always interpret percentage together with absolute free concentration, seizure control, sedation, nystagmus, ataxia, cognition changes, and other toxicity markers.
Clinical Data: Why Free Monitoring Matters
Multiple clinical cohorts have shown discordance between total and free phenytoin interpretation, especially when albumin is low or renal function is impaired. Reported misclassification rates differ by population, lab methods, and formula choice, but the trend is consistent: reliance on total concentration alone can produce dose decisions opposite to what free levels suggest.
| Published Clinical Pattern | Reported Statistic | What It Means at Bedside |
|---|---|---|
| Phenytoin protein binding in general adult populations | About 90% bound, about 10% free (classic pharmacology reference range) | Free concentration is small in proportion but drives effect and toxicity |
| Hospitalized or ICU hypoalbuminemia prevalence | Often approximately 40% to 60% depending on cohort and severity | A large fraction of inpatients may have altered phenytoin binding |
| Discordance of calculated vs measured free phenytoin in complex patients | Commonly about 20% to 40%, with higher rates in renal dysfunction cohorts | Equation estimates are screening tools, not final truth in unstable patients |
| Therapeutic target relationship | Total 10 to 20 mcg/mL generally corresponds to free 1 to 2 mcg/mL | When albumin or uremia changes binding, this relationship can break down |
When to Order a Measured Free Phenytoin Level Immediately
- Albumin clearly reduced, especially below about 3.0 to 3.5 g/dL
- Moderate to severe kidney dysfunction, uremia, or dialysis
- Neurologic toxicity signs despite “therapeutic” total concentration
- Persistent seizures despite apparently adequate total concentration
- Major acute illness (sepsis, trauma, burn injury), changing volume status, or multiple interacting drugs
Important Formula Context and Limitations
Albumin-based equations can improve interpretation over raw total concentration in selected settings, but they remain approximations. They cannot fully capture patient-specific changes in binding affinity, acid-base effects, co-administered drugs, inflammatory states, and assay variation. In real-world practice, calculated free fraction helps triage decisions, while measured free concentration confirms true exposure.
Use these safety principles:
- Never escalate dose aggressively based only on low total level when albumin is low.
- If symptoms suggest toxicity, prioritize measured free level even if total is “normal.”
- Trend values over time rather than reacting to a single isolated concentration.
- Coordinate pharmacokinetic interpretation with neurology, pharmacy, or toxicology support when available.
Worked Example
Suppose total phenytoin is 12 mcg/mL and measured free is 2.1 mcg/mL. The percent free fraction is:
(2.1 / 12) × 100 = 17.5%
Even though total level sits in a commonly therapeutic range, the free fraction is elevated and free absolute concentration exceeds the usual 1 to 2 mcg/mL target. This pattern can match early toxicity in susceptible patients. If the patient has ataxia or nystagmus, dose reassessment and close follow-up are warranted.
Medication and Lab Considerations
Phenytoin has saturable metabolism, so small dose adjustments can create larger-than-expected concentration shifts. Timing of blood draw matters: trough sampling at steady state supports cleaner interpretation. Lab methods for free concentration may also differ by institution (for example ultrafiltration workflow and assay platform), which can affect cross-lab comparability.
- Document sample timing relative to last dose.
- Use consistent laboratory methods when possible for serial trending.
- Correlate with liver function, renal function, albumin, and interacting medication list.
Key Takeaways
To calculate percent free fraction phenytoin, divide free concentration by total concentration and multiply by 100. This number gives immediate insight into how much active drug is circulating unbound. In stable patients, expected values are often near 10%. In hypoalbuminemia, uremia, or critical illness, free fraction can rise significantly, and total level alone may mislead management. Use calculated estimates as a bridge, but rely on measured free concentrations whenever risk is high or the clinical picture is inconsistent.